Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Tinea Corporis Causative Organisms and Treatment

Geographic and Population Variations

  • In athletic populations, particularly wrestlers and judo practitioners, Trichophyton tonsurans is the dominant pathogen, accounting for more than 80% of tinea corporis gladiatorum cases 1, 2
  • Trichophyton rubrum and Trichophyton mentagrophytes are also recognized as common causative agents, particularly in non-athletic populations 1, 2
  • Studies of wrestlers show remarkably high prevalence rates: 24% of wrestlers had tinea corporis lesions versus 0% in control groups, and 53% of judo practitioners aged 15-17 years were affected 1, 2

Clinical Implications for Treatment

  • Terbinafine demonstrates superior efficacy for T. tonsurans infections compared to other antifungal agents 1, 2, 3
  • Itraconazole 100 mg daily for 15 days achieves 87% mycological cure rates in adolescents and adults, significantly superior to griseofulvin's 57% cure rate 1, 2, 3
  • The definitive endpoint for adequate treatment should be mycological cure (negative microscopy and culture), not just clinical improvement, as clinical appearance may improve while infection persists 3